Literature DB >> 24440602

The ABC of BTC: structural properties and biological roles of betacellulin.

Maik Dahlhoff1, Eckhard Wolf1, Marlon R Schneider2.   

Abstract

Betacellulin was initially detected as a growth-promoting factor in the conditioned medium of a mouse pancreatic β-cell tumor cell line. Sequencing of the purified protein and of the cloned cDNA supported the assumption that betacellulin is a new ligand of the epidermal growth factor receptor (EGFR), which was later confirmed experimentally. As a typical EGFR ligand, betacellulin is expressed by a variety of cell types and tissues, and the soluble growth factor is proteolytically cleaved from a larger membrane-anchored precursor. Importantly, BTC can - in addition to the EGFR - bind and activate all possible heterodimeric combinations of the related ERBB receptors including the highly oncogenic ERBB2/3 dimer, as well as homodimers of ERBB4. While a large number of studies attest a role for betacellulin in the differentiation of pancreatic β-cells, the last decade witnessed the association of betacellulin with a large number of additional biological processes, ranging from reproduction to the control of neural stem cells.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Betacellulin; Cancer; Cell signaling; Diabetes; Epidermal growth factor receptor; Growth factors

Mesh:

Substances:

Year:  2014        PMID: 24440602     DOI: 10.1016/j.semcdb.2014.01.002

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  8 in total

1.  Induction of lateral lumens through disruption of a monoleucine-based basolateral-sorting motif in betacellulin.

Authors:  Bhuminder Singh; Galina Bogatcheva; Alina Starchenko; Justine Sinnaeve; Lynne A Lapierre; Janice A Williams; James R Goldenring; Robert J Coffey
Journal:  J Cell Sci       Date:  2015-08-13       Impact factor: 5.285

2.  Dual blockade of STAT3 and EGFR: a key to unlock drug resistance in glioblastoma?

Authors:  Sabrina Fritah; Simone P Niclou
Journal:  Neuro Oncol       Date:  2020-04-15       Impact factor: 12.300

3.  BTC as a Novel Biomarker Contributing to EMT via the PI3K-AKT Pathway in OSCC.

Authors:  Ting Shen; Tianru Yang; Mianfeng Yao; Ziran Zheng; Mi He; Mengying Shao; Jiang Li; Changyun Fang
Journal:  Front Genet       Date:  2022-07-01       Impact factor: 4.772

4.  Betacellulin drives therapy resistance in glioblastoma.

Authors:  Qiwen Fan; Zhenyi An; Robyn A Wong; Xujun Luo; Edbert D Lu; Albert Baldwin; Manasi K Mayekar; Franziska Haderk; Kevan M Shokat; Trever G Bivona; William A Weiss
Journal:  Neuro Oncol       Date:  2020-04-15       Impact factor: 12.300

Review 5.  EGF receptor ligands: recent advances.

Authors:  Bhuminder Singh; Graham Carpenter; Robert J Coffey
Journal:  F1000Res       Date:  2016-09-08

6.  Betacellulin promotes tumor development and EGFR mutant lung cancer growth by stimulating the EGFR pathway and suppressing apoptosis.

Authors:  Suresh Chava; Suresh Bugide; Xuchen Zhang; Romi Gupta; Narendra Wajapeyee
Journal:  iScience       Date:  2022-04-06

7.  Experimental and Clinical Evidence Suggests That Treatment with Betacellulin Can Alleviate Th2-Type Cytokine-Mediated Impairment of Skin Barrier Function.

Authors:  Ge Peng; Saya Tsukamoto; Yoshie Umehara; Ryoma Kishi; Mitsutoshi Tominaga; Kenji Takamori; Ko Okumura; Hideoki Ogawa; Shigaku Ikeda; François Niyonsaba
Journal:  Int J Mol Sci       Date:  2022-09-29       Impact factor: 6.208

8.  Betacellulin induces Slug-mediated down-regulation of E-cadherin and cell migration in ovarian cancer cells.

Authors:  Jianfang Zhao; Christian Klausen; Xin Qiu; Jung-Chien Cheng; Hsun-Ming Chang; Peter C K Leung
Journal:  Oncotarget       Date:  2016-05-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.